Centanafadine Hydrochloride

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

2 competitors in Attention Deficit/Hyperactivity Disorder

Drug Information

Target Indication

Attention Deficit/Hyperactivity Disorder

Clinical Trial

Last updated: 2/14/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

CODX

Co-Diagnostics, Inc.

Related Pipeline

Hypercholesterolemia

Clostridium Difficile Infection

Osteoporosis, Postmenopausal

DLBCL

Sedation in Intensive Care